TDC A/S
3.5.2021 14:01:54 CEST | Globenewswire | Press release
TDC will conduct a conference call for investors and analysts on March 6, 2021 at 14.30 CET to present the Q1 2021 results. Lasse Pilgaard, Chief Financial Officer, will comment on the results and answer questions during the conference call.
The investor and analyst conference will be available in Microsoft Teams at:
Dial in to Microsoft Teams is: +45 32 72 51 67 – Code: 256 316 081#
The conference call will refer to a slide deck that will be available from March 6, 2021 at approx. 10.00 CET on the link:
https://tdcgroup.com/en/investor-relations
Please mute your microphone before and during the presentation.
For inquiries regarding the above please contact TDC Investor Relations on +45 6663 7680 or investorrelations@tdc.dk.
TDC tickers
Reuters TDC.CO.
Bloomberg TDC DC.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Holafly27.3.2026 13:56:09 CET | Press release
Earth Month 2026: 42% of travelers say they take steps to travel more responsibly, according to Holafly
Nykredit Realkredit A/S27.3.2026 13:54:38 CET | Press release
Correction: Announcement of drawings (CK95) - Nykredit Realkredit A/S
Nykredit Realkredit A/S27.3.2026 13:54:38 CET | Pressemeddelelse
Correction: Udtrækningsmeddelelse (CK95) - Nykredit Realkredit A/S
Royal UNIBREW A/S27.3.2026 13:03:03 CET | Press release
Notice to convene the Annual General Meeting in Royal Unibrew A/S
Sanofi Winthrop Industrie27.3.2026 13:00:00 CET | Press release
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
